MXF

(2S,3R)-4-(2-aminoethylcarbamoyloxy)-2-[(2-methanoylindolizin-3-yl)amino]-3-methyl-3-sulfino-butanoic acid

Created:	2009-01-28
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where MXF is found as a standalone ligand1 entries where MXF is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	51
Chiral Atom Count	2
Bond Count	52
Aromatic Bond Count	10

2D diagram of MXF

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S,3R)-4-(2-aminoethylcarbamoyloxy)-2-[(2-methanoylindolizin-3-yl)amino]-3-methyl-3-sulfino-butanoic acid
Synonyms	penam sulfone SA3-53, open form
Systematic Name (OpenEye OEToolkits)	(2S,3R)-4-(2-azanylethylcarbamoyloxy)-2-[(2-methanoylindolizin-3-yl)amino]-3-methyl-3-[(R)-oxidanylsulfinyl]butanoic acid
Formula	C₁₇ H₂₂ N₄ O₇ S
Molecular Weight	426.444
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)C(Nc2c(cc1ccccn12)C=O)C(S(=O)O)(C)COC(=O)NCCN
SMILES	CACTVS	3.370	C[C](COC(=O)NCCN)([CH](Nc1n2ccccc2cc1C=O)C(O)=O)[S](O)=O
SMILES	OpenEye OEToolkits	1.7.6	CC(COC(=O)NCCN)(C(C(=O)O)Nc1c(cc2n1cccc2)C=O)S(=O)O
Canonical SMILES	CACTVS	3.370	C[C@](COC(=O)NCCN)([C@@H](Nc1n2ccccc2cc1C=O)C(O)=O)[S](O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.6	C[C@](COC(=O)NCCN)([C@H](C(=O)O)Nc1c(cc2n1cccc2)C=O)[S@](=O)O
InChI	InChI	1.03	InChI=1S/C17H22N4O7S/c1-17(29(26)27,10-28-16(25)19-6-5-18)13(15(23)24)20-14-11(9-22)8-12-4-2-3-7-21(12)14/h2-4,7-9,13,20H,5-6,10,18H2,1H3,(H,19,25)(H,23,24)(H,26,27)/t13-,17-/m0/s1
InChIKey	InChI	1.03	UGXGYKKZKHIUJW-GUYCJALGSA-N

Related Resource References

Resource Name	Reference
PubChem	49867347

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.